Whittaker A, Anson M, Harky A. Neurological manifestations of COVID-19: a systematic review and current update. Acta Neurol Scand. 2020;142:14–22. https://doi.org/10.1111/ane.13266.
CAS Article PubMed Google Scholar
Sfera A, Osorio C, Maguire G, Rahman L, Afzaal J, Cummings M, et al. COVID-19, ferrosenescence and neurodegeneration, a mini-review. Prog Neuro-Psychopharmacol Biol Psychiatry. 2021;109: 110230. https://doi.org/10.1016/j.pnpbp.2020.110230.
Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370:856–60. https://doi.org/10.1126/science.abd2985.
CAS Article PubMed PubMed Central Google Scholar
Jiang S, Hillyer C, Du L. Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses. Trends Immunol. 2020;41:5. https://doi.org/10.1016/j.it.2020.03.007.
Xu J, Lazartigues E. Expression of ACE2 in human neurons supports the neuro-invasive potential of COVID-19 virus. Cell Mol Neurobiol. 2020;42(1):305–9. https://doi.org/10.1007/s10571-020-00915-1.
CAS Article PubMed PubMed Central Google Scholar
Lima M, Siokas V, Aloizou AM, Liampas L, Mentis AFA, Tsouris Z, et al. Unraveling the possible routes of SARS-COV-2 invasion into the central nervous system. Curr Treat Options Neurol. 2020;22:37. https://doi.org/10.1007/s11940-020-00647-z.
Article PubMed PubMed Central Google Scholar
Paniz-Mondolfi A, Bryce C, Grimes Z, Gordon RE, Reidy J, Lednicky J, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol. 2020;92:699–702. https://doi.org/10.1002/jmv.25915.
CAS Article PubMed Google Scholar
Bidram E, Esmaeili Y, Amini A, Sartorius R, Tay FR, Shariati L, et al. Nanobased platforms for diagnosis and treatment of COVID-19: from benchtop to bedside. ACS Biomater Sci Eng. 2021;7:2150–76. https://doi.org/10.1021/acsbiomaterials.1c00318.
CAS Article PubMed PubMed Central Google Scholar
Morris M, Zohrabian VM. Neuroradiologists, be mindful of the neuroinvasive potential of COVID-19. Am J Neuroradiol. 2020;41:6. https://doi.org/10.3174/ajnr.A6551.
Welcome MO, Mastorakis NE. Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection. Inflammopharmacology. 2021;29:4. https://doi.org/10.1007/s10787-021-00806-x.
Nagu P, Parashar A, Behl T, Mehta V. CNS implications of COVID-19: a comprehensive review. Rev Neurosci. 2021;32:219–34. https://doi.org/10.1515/revneuro-2020-0070.
CAS Article PubMed Google Scholar
Bohmwald K, Gálvez NMS, Ríos M, Kalergis AM. Neurologic alterations due to respiratory virus infections. Front Cell Neurosci. 2018;12:386. https://doi.org/10.3389/fncel.2018.00386.
CAS Article PubMed PubMed Central Google Scholar
Lippi A, Domingues R, Setz C, Outeiro TF, Krisko A. SARS-CoV-2: At the crossroad between aging and meurodegeneration. Mov Disord. 2020;35:5. https://doi.org/10.1002/mds.28084.
Jungreis I, Sealfon R, Kellis M. SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes. Nat Commun. 2021;12:2642. https://doi.org/10.1038/s41467-021-22905-7.
CAS Article PubMed PubMed Central Google Scholar
Prajapat M, Sarma P, Shekhar N, Avti P, Sinha S, Kaur H, et al. Drug for corona virus: A systematic review. Indian J Pharmacol. 2020;52:1. https://doi.org/10.4103/ijp.IJP_115_20.
Article PubMed PubMed Central Google Scholar
Shi CS, Nabar NR, Huang NN, Kehrl JH. SARS-coronavirus open reading frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes. Cell Death Discov. 2019;5:1. https://doi.org/10.1038/s41420-019-0181-7.
Morin CM, Bjorvatn B, Chung F, Holzinger B, Partinen M, Penzel T, et al. Insomnia, anxiety, and depression during the COVID-19 pandemic: an international collaborative study. Sleep Med. 2021;87:385–445. https://doi.org/10.1016/j.sleep.2021.07.035.
Costello F, Dalakas MC. Cranial neuropathies and COVID-19. Neurology. 2020;95:5. https://doi.org/10.1212/WNL.0000000000009921.
McQuaid C, Brady M, Deane R. SARS-CoV-2: is there neuroinvasion? Fluids Barriers CNS. 2021;18:32. https://doi.org/10.1186/s12987-021-00267-y.
CAS Article PubMed PubMed Central Google Scholar
Guzman-Martinez L, Maccioni RB, Andrade V, Navarrete LP, Pastor MG, Ramos-Escobar N. Neuroinflammation as a common feature of neurodegenerative disorders. Front Pharmacol. 2019;10:1008. https://doi.org/10.3389/fphar.2019.01008.
CAS Article PubMed PubMed Central Google Scholar
Sen R, Garbati M, Bryant K, Lu Y. Epigenetic mechanisms influencing COVID-19. Genome. 2021;64:372–85. https://doi.org/10.1139/gen-2020-0135.
CAS Article PubMed Google Scholar
Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18–22. https://doi.org/10.1016/j.bbi.2020.03.031.
CAS Article PubMed PubMed Central Google Scholar
Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595:565–71. https://doi.org/10.1038/s41586-021-03710-0.
CAS Article PubMed PubMed Central Google Scholar
Gutiérrez-Ortiz C, Méndez-Guerrero A, Rodrigo-Rey S, Pedro-Murillo ES, Bermejo-Guerrero L, Gordo-Mañas R, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95:e601–5. https://doi.org/10.1212/WNL.0000000000009619.
CAS Article PubMed Google Scholar
Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382:2268–70. https://doi.org/10.1056/NEJMc2008597.
Rhea EM, Logsdon AF, Hansen KM, Williams LM, Reed MJ, Baumann KK, et al. The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice. Nat Neurosci. 2021;24:368–78. https://doi.org/10.1038/s41593-020-00771-8.
CAS Article PubMed Google Scholar
Sulzer D, Antonini A, Leta V, Nordvig A, Smeyne RJ, Goldman JE, et al. COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside. NPJ Park Dis. 2020;6:1. https://doi.org/10.1038/s41531-020-00123-0.
Cascella M, De Blasio E. Pathophysiology of COVID-19-associated neurotoxicity. In: Features and Management of Acute and Chronic Neuro-Covid, Cham: Springer International Publishing, 2022, pp. 1–41.
Jacob A, Alexander JJ. Complement and blood–brain barrier integrity. Mol Immunol. 2014;61:2. https://doi.org/10.1016/j.molimm.2014.06.039.
Jiang Y, Li J, Teng Y, Sun H, Tian G, He L, et al. Complement receptor C5aR1 inhibition reduces pyroptosis in hDPP4-transgenic mice infected with MERS-CoV. Viruses. 2019;11:1. https://doi.org/10.3390/v11010039.
Rojas M, Restrepo-Jiménez P, Monsalve DM, Pacheco Y, Acosta-Ampudia Y, Ramírez-Santana C, et al. Molecular mimicry and autoimmunity. J Autoimmun. 2018;95:100–23. https://doi.org/10.1016/j.jaut.2018.10.012.
CAS Article PubMed Google Scholar
Kasperkiewicz M. Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention. Cell Stress Chaperones. 2021;26:1–2. https://doi.org/10.1007/s12192-020-01180-3.
CAS Article PubMed Google Scholar
Lucchese G, Flöel A. SARS-CoV-2 and Guillain-Barré syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism. Cell Stress Chaperones. 2020;25:5. https://doi.org/10.1007/s12192-020-01145-6.
McWilliam M, Samuel M, Alkufri FH. Neuropathic pain post-COVID-19: a case report. BMJ Case Rep. 2021;14:7. https://doi.org/10.1136/BCR-2021-243459.
Mangalmurti N, Hunter CA. Cytokine storms: Understanding COVID-19. Immunity. 2020;53:19–25. https://doi.org/10.1016/j.immuni.2020.06.017.
CAS Article PubMed PubMed Central Google Scholar
Hojyo S, Uchida M, Tanaka K, Hasebe R, Tanaka Y, Murakami M, et al. How COVID-19 induces cytokine storm with high mortality. Inflamm Regen. 2020;40:37. https://doi.org/10.1186/s41232-020-00146-3.
CAS Article PubMed PubMed Central Google Scholar
Pensato U, Muccioli L, Janigro D, Guarino M, Bisulli F, Cortelli P. Akinetic mutism in COVID-19-related encephalopathy: a cytokine-mediated maladaptive sickness behavioral response? Brain Behav Immun Heal. 2021;15: 100272. https://doi.org/10.1016/j.bbih.2021.100272.
Pilotto A, Odolini S, Masciocchi S, Comelli A, Volonghi I, Gazzina S, et al. Steroid-responsive encephalitis in coronavirus disease 2019. Ann Neurol. 2020;88:2. https://doi.org/10.1002/ana.25783.
Farhadian S, Glick LR, Vogels CBF, Thomas J, Chiarella J, Casanovas-Massana A, et al. Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19. BMC Neurol. 2020;20:1. https://doi.org/10.1186/s12883-020-01812-2.
留言 (0)